H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares traded.
H. Lundbeck A/S Stock Performance
The stock has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71. The firm has a 50 day moving average of $22.00 and a two-hundred day moving average of $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Further Reading
- Five stocks we like better than H. Lundbeck A/S
- What Are Dividends? Buy the Best Dividend Stocks
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- Comparing and Trading High PE Ratio Stocks
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
